Chile is tendering for radiopharmaceutical project in prostate cancer

The Chilean Nuclear Energy Commission (CCHEN) is formulating a research and development (R & D) project aimed at developing a radiopharmaceutical for the detection of prostate cancer.

The proposal, which will be presented to the Corfo Crea and Valida contest for its co-financing, allows for the intervention of an investor or collaborator entity that is involved in achieving the results of said project.

Review requirements and conditions here.

http://www.cchen.cl/wp-content/uploads/2019/01/Lllamado-a-presentar-declaraci%C3%B3n-de-interes_Corfo_2019-1.pdf

Arnaud Lefevre

Arnaud Lefevre

Arnaud Lefevre is the Chief Executive Officer of Dynatom International. Arnaud is in charge of the international development of the business portfolio.
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Don’t Stop Here

Jordan Begins Production of Yellow Cake

A specialized team from the Research Laboratories and Information Directorate at the Jordan Atomic Energy Commission (JAEC) has recently extracted Uranium from ores in central

The progress of the Yanlong reactor

On April 26, Rong Jian, deputy director of the China Nuclear Power Development Center, a department of the National Energy Administration, went to China Institute

Congo Restarts its Nuclear Program

The Council of Ministers of the Democratic Republic of Congo (DRC) approved the restart of the Triga II reactor in Kinshasa. The Congolese authorities will

Scroll to Top